Athanase Innovation AB (OSTO:ATIN) Debt-to-Equity: 0.00 (As of Dec. 2020)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:ATIN Athanase Innovation AB OSTO:ATIN
26 GF Score
Price kr20.40
View Full Analysis

What is Athanase Innovation AB Debt-to-Equity?

Athanase Innovation AB OSTO:ATIN 26 Debt-to-Equity is 0.00 as of Dec. 2020. GuruFocus rates OSTO:ATIN with a GF Score™ of 26/100.

Athanase Innovation AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was kr0.00 Mil. Athanase Innovation AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was kr0.00 Mil. Athanase Innovation AB's Total Stockholders Equity for the quarter that ended in Dec. 2020 was kr396.75 Mil. Athanase Innovation AB's debt to equity for the quarter that ended in Dec. 2020 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Athanase Innovation AB's Debt-to-Equity or its related term are showing as below:

OSTO:ATIN's Debt-to-Equity is not ranked *
in the Asset Management industry.
Industry Median: 0.22
* Ranked among companies with meaningful Debt-to-Equity only.

Athanase Innovation AB  (OSTO:ATIN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Athanase Innovation AB Debt-to-Equity Related Terms

Athanase Innovation AB Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for Athanase Innovation AB's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Athanase Innovation AB Debt-to-Equity Chart

Athanase Innovation AB Annual Data
Trend Jun17 Jun18 Jun19
Debt-to-Equity
1.43 1.47 1.54

Athanase Innovation AB Semi-Annual Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20
Debt-to-Equity Get a 7-Day Free Trial 1.57 1.54 1.66 1.63 0.00

OSTO:ATIN vs EVG, SMM, NHS: Debt-to-Equity Comparison

For the Asset Management subindustry, Athanase Innovation AB's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Athanase Innovation AB Debt-to-Equity vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Athanase Innovation AB's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Athanase Innovation AB's Debt-to-Equity falls into.


OSTO:ATIN
26GF Score
Athanase Innovation AB OSTO:ATIN
Debt-to-Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Athanase Innovation AB Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Athanase Innovation AB's Debt to Equity Ratio for the fiscal year that ended in Jun. 2019 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(4.1 + 397.7) / 260.433
=1.54

Athanase Innovation AB's Debt to Equity Ratio for the quarter that ended in Dec. 2020 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0 + 0) / 396.748
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of 0.00 mean?
Athanase Innovation AB (OSTO:ATIN) has a Debt-to-Equity of 0.00 as of Dec. 2020. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Athanase Innovation AB and its competitors.
Is Athanase Innovation AB's Debt-to-Equity too high?
Athanase Innovation AB's current Debt-to-Equity is 0.00. Overall, Athanase Innovation AB has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Athanase Innovation AB's Debt-to-Equity compare to EVG and SMM?
Athanase Innovation AB's Debt-to-Equity of 0.00 can be compared against companies in the Asset Management industry. The industry median Debt-to-Equity is 0.22. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for an Asset Management company?
The median Debt-to-Equity among Asset Management companies is 0.22, based on 933 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Athanase Innovation AB and its competitors. For the Asset Management industry, the median Debt-to-Equity is 0.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Athanase Innovation AB's current Debt-to-Equity is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Athanase Innovation AB stock overvalued right now?
Athanase Innovation AB (OSTO:ATIN) has a current Debt-to-Equity of 0.00. The current Debt-to-Equity is 0.00. Athanase Innovation AB's overall GF Score™ is 26/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Athanase Innovation AB (OSTO:ATIN), the current Debt-to-Equity is 0.00 as of Dec. 2020. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Athanase Innovation AB Business Description

Address Birger Jarlsgatan 6, Sverige, Stockholm, SWE, 114 34
Athanase Innovation AB is an alternative investment firm with exposure to both private and public equity. It invests in innovative companies that benefit from trends such as robotics, digitalization, and automation. The principal revenue stream is initially management fees charged on the external fund capital and investment income of the underlying assets.
26GF Score

Get the complete analysis for OSTO:ATIN

Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.40
Price